Grupo Genetrix
Corporate investor
Active
1
37M
1
1
- Stages of investment
- Areas of investment
Summary
The venture was found in Europe in Spain. The leading representative office of defined Corporate Investor is situated in the Madrid.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Grupo Genetrix, startups are often financed by Ysios Capital, Ventech, Roche Venture Fund. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Ventech, Roche Venture Fund.
Among the most successful fund investment fields, there are Pharmaceutical, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Cellerix. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Spain.
The high activity for fund was in 2010. The higher amount of exits for fund were in 2011. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Pharmaceutical (1)
- Biotechnology (1)
- Medical (1)
- Investments by region
-
- Spain (1)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Avg. valuation at time of investment
- 79M
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
- Avg. multiplicator
- 0.79
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cellerix | 28 Jan 2010 | Biotechnology, Medical, Pharmaceutical | Late Stage Venture | 37M | Community of Madrid, Madrid, Spain |
Similar funds
By same location
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.